Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for the Treatment of Breast Cancer, Non-small Cell Lung Cancer, Prostata-carcinoma, Adenocarcinoma of the Stomach and Advanced Squamous Cell Carcinoma of the Head/Neck Region.
Time Perspective: Prospective
the quantity of Doce onkovis needed pro treatment cycle
Determine the quantity of Doce onkovis needed pro treatment cycle
the time the participants will be followed depends on the number of treatment cycles; that means the time frame may extend up to 24 weeks (8 cycles).
Germany: Federal Institute for Drugs and Medical Devices